Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNexus Gene Lab (BGLC) Asset Utilization Ratio (2019 - 2025)

BioNexus Gene Lab's Asset Utilization Ratio history spans 7 years, with the latest figure at 0.88 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.88 for Q4 2025, down 0.86% from a year ago — trailing twelve months through Dec 2025 was 0.88 (down 0.86% YoY), and the annual figure for FY2025 was 0.75, down 13.42%.
  • Asset Utilization Ratio for Q4 2025 was 0.88 at BioNexus Gene Lab, down from 1.11 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.48 in Q3 2021 to a low of 0.82 in Q2 2024.
  • The 5-year median for Asset Utilization Ratio is 1.14 (2021), against an average of 1.14.
  • The sharpest move saw Asset Utilization Ratio plummeted 78.99% in 2021, then skyrocketed 32.76% in 2025.
  • Year by year, Asset Utilization Ratio stood at 1.38 in 2021, then decreased by 4.36% to 1.32 in 2022, then crashed by 35.33% to 0.85 in 2023, then grew by 3.86% to 0.89 in 2024, then decreased by 0.86% to 0.88 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.88, 1.11, and 1.01 for Q4 2025, Q3 2025, and Q2 2025 respectively.